|
English
|
正體中文
|
简体中文
|
總筆數 :2851814
|
|
造訪人次 :
44847654
線上人數 :
1409
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"conte p"的相關文件
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-04-26T08:05:28Z |
Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2–positive breast cancer
|
Conte P.;Schneeweiss A.;Loibl S.;Mamounas E.P.;Von Minckwitz G.;Mano M.S.;Untch M.;Chiun-Sheng Huang;Wolmark N.;Rastogi P.;D’Hondt V.;Redondo A.;Stamatovic L.;Bonnefoi H.;Castro-Salguero H.;Fischer H.H.;Wahl T.;Song C.;Boulet T.;Trask P.;Geyer C.E.;Jr.; Conte P.; Schneeweiss A.; Loibl S.; Mamounas E.P.; von Minckwitz G.; Mano M.S.; Untch M.; CHIUN-SHENG HUANG; Wolmark N.; Rastogi P.; D’Hondt V.; Redondo A.; Stamatovic L.; Bonnefoi H.; Castro-Salguero H.; Fischer H.H.; Wahl T.; Song C.; Boulet T.; Trask P.; Geyer C.E.; Jr. |
| 臺大學術典藏 |
2021-04-23T05:56:28Z |
Tepotinib in non-small-cell lung cancer with MET exon 14 skipping mutations
|
Paik P.K.;Felip E.;Veillon R.;Sakai H.;Cortot A.B.;Garassino M.C.;Mazieres J.;Viteri S.;Senellart H.;Van Meerbeeck J.;Raskin J.;Reinmuth N.;Conte P.;Kowalski D.;Cho B.C.;Patel J.D.;Horn L.;Griesinger F.;Han J.-Y.;Kim Y.-C.;Chang G.-C.;Tsai C.-L.;Chih-Hsin Yang;Chen Y.-M.;Smit E.F.;Van Der Wekken A.J.;Kato T.;Juraeva D.;Stroh C.;Bruns R.;Straub J.;Johne A.;Scheele J.;Heymach J.V.;Le X.; Paik P.K.; Felip E.; Veillon R.; Sakai H.; Cortot A.B.; Garassino M.C.; Mazieres J.; Viteri S.; Senellart H.; van Meerbeeck J.; Raskin J.; Reinmuth N.; Conte P.; Kowalski D.; Cho B.C.; Patel J.D.; Horn L.; Griesinger F.; Han J.-Y.; Kim Y.-C.; Chang G.-C.; Tsai C.-L.; CHIH-HSIN YANG; Chen Y.-M.; Smit E.F.; van der Wekken A.J.; Kato T.; Juraeva D.; Stroh C.; Bruns R.; Straub J.; Johne A.; Scheele J.; Heymach J.V.; Le X. |
| 臺大學術典藏 |
2020-05-25T06:51:45Z |
Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
|
Ciruelos E.M; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.; Andr? F; Andr? F;Ciruelos E.M;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D. |
| 臺大學術典藏 |
2020-05-25T06:51:45Z |
Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): Results of the phase III SOLAR-1 trial
|
Ciruelos E.M; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D.; Andr? F; Andr? F;Ciruelos E.M;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D. |
| 臺大學術典藏 |
2020-05-25T06:51:43Z |
Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer
|
Andr? F;Ciruelos E;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D.; Andr? F; Ciruelos E; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D. |
| 臺大學術典藏 |
2020-05-25T06:51:43Z |
Alpelisib for PIK3CA-mutated, hormone receptor-positive advanced breast cancer
|
Andr? F;Ciruelos E;Rubovszky G;Campone M;Loibl S;Rugo H.S;Iwata H;Conte P;Mayer I.A;Kaufman B;Yamashita T;Yen-Shen Lu;Inoue K;Takahashi M;P?Pai Z;Longin A.-S;Mills D;Wilke C;Hirawat S;Juric D.; Andr? F; Ciruelos E; Rubovszky G; Campone M; Loibl S; Rugo H.S; Iwata H; Conte P; Mayer I.A; Kaufman B; Yamashita T; YEN-SHEN LU; Inoue K; Takahashi M; P?pai Z; Longin A.-S; Mills D; Wilke C; Hirawat S; Juric D. |
顯示項目 1-6 / 6 (共1頁)
1
每頁顯示[10|25|50]項目
|
